Private label ·
Planning a private-label nasal spray project: from market to packaging
A nasal spray project takes shape when the target market, indication and available product are considered together. At VITROBIO, the starting point is an existing formulation, with commercial arrangements assessed with the partner.
Describe the need before choosing a product
“We are looking for a nasal spray” leaves several questions unanswered. Which need should the range address? In which countries will it be distributed? For which users and through which channels? These answers make it possible to discuss a specific product rather than generic packaging.
For example, a company already distributing ENT products through pharmacies may want to expand its nasal care range in two markets. Its brief can identify the indications already covered, the gap in its range and its language requirements. This is an example of how to prepare a project, not confirmation of commercial availability.
Match the indication to an existing formulation
The device’s intended purpose guides product selection. Allerspray addresses allergic rhinitis; Nesospray is presented for rhinopharyngitis and rhinosinusitis. Their product pages describe the respective uses and available data. A shared symptom, such as nasal congestion, does not make two products interchangeable.
Private label does not mean a new formula made to order. VITROBIO’s offering is based on formulations developed and evaluated by the laboratory. Options are assessed against the indication, market and existing distribution agreements. The partner FAQ explains this approach.
Prepare a brief the teams can work with
Gather the following information for the initial discussion:
- Target countries and languages needed for the materials.
- The gap in your range and the indication you are seeking.
- The VITROBIO product under consideration, if already identified.
- Distribution channels and the intended commercial presentation.
- Forecast volumes and the desired launch period.
- Known storage, transport or packaging constraints.
A forecast helps assess the project; it is neither an order nor a reservation of production capacity. Minimum quantities, availability and lead times must be confirmed for the chosen product and packaging. It is better to write “to be confirmed” than to build a schedule around an unverified assumption.
Review packaging before finalising artwork
Your brand can be the starting point for artwork, but the carton content must remain consistent with the selected device. Confirm the reference format, instructions for use, required wording, operator identification and language version. Any requested change to the bottle or presentation needs discussion; it should not be assumed possible.
At VITROBIO, the laboratory remains the legal manufacturer and the partner is identified as the distributor. The teams examine the documentation and responsibilities for the target country together. Our article on regulatory documents to review helps prepare this discussion.
Move from the brief to a decision
After the initial exchange, distinguish confirmed points from those still under review: product, territory, packaging, documentation and commercial terms. This provides a shared follow-up list for commercial and regulatory teams.
To compare indications within a portfolio, read about building an ENT range. You can then present your private-label project to VITROBIO, with your brief and the questions still open.